C. auris, first identified in 2009 in Asia, has quickly become a cause of severe infections around the world. C. auris is a concerning drug-resistant fungus. It can cause outbreak in healthcare fa...
Day 2 at ISHAM 2022
New Delhi, India – September 21, 2022 – Genobio with Indian local Partner Bio-State is participating 21th congress of the International Society for Human and Animal Mycology (IS...
YY/T 1729-2020 “Fungus (1-3)-β-D-Glucan Test” formulated by Era Biology was approved by NMPA on July 9, 2020 and officially released. The standard will be formally implemented on June 1...
Tianjin, China – September 28, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and pioneer of invasive fungal disease diagnostic field sinc...
The 32nd European Congress of Clinical Microbiology and Infectious Diseases, which will take place for the first time as a hybrid event both online and on-site in Lisbon.
Era Biology will offer fu...
ERA BIOLOGY Great Show at Africa Health 2022
Gallagher Convention Center, Johannesburg, South Africa – 26th-28th October – ERA BIOLOGY participated in Africa Health 2022, which is the most influent...